Infectious diseases

Promise with new triple drug combo for resistant TB

A new triple therapy for extensively drug-resistant (XDR) tuberculosis and complicated forms of multidrug-resistant (MDR) tuberculosis may replace the multi-drug regimens currently in use and offers some promise in the race to meet WHO End TB goals.  An open-label, single-group study across three sites in South Africa has found the all-oral combination of bedaquiline, pretomanid ...

Already a member?

Login to keep reading.

© 2021 the limbic